Stock Market Kicks off New Month With Uncertainty, Ahead of Fed Meeting, More Earnings

Brian Vendig, president of MJP Wealth Advisors, joined Cheddar News to discuss the market ahead of the Federal Reserve's meeting on Wednesday and as investors digest JPMorgan's takeover of First Republic Bank, which was recently seized by regulators. A slew of earnings are also slated to be released this week as well.

More In Business

Morning Alexa Flash Briefings of May 30th

Morning Alexa Flash Briefings

Debt Ceiling Deal Goes for Vote This Week as Biden Calls Lawmakers for Support

Some House Democrats will have to vote for McCarthy's bill if enough conservative Republicans keep their word to oppose any compromise.

Blue Bird Opens Electric School Bus Factory

Blue Bird, a maker of school buses, opened up a production facility to meet the rising demand for electric school buses.

Eating Disorder Helpline to Replace Staff With A.I.

The National Eating Disorders Association said it's replacing its staff with an artificial intelligence chatbot.

Hyundai and LG Partner For EV Battery Plant

Hyundai and LG announced a partnership to build a $4.3 billion electric battery plant in Georgia.

JPMorgan Cuts 1,000 First Republic Bank Jobs

JPMorgan announced job cuts at First Republic Bank, a month after acquiring the company.

AstraZeneca: Positive Results in Endometrial Cancer Trial

AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.

Historic U.S. Lighthouses Up For Grabs

The federal government is giving away for free some historic lighthouses and is also auctioning some of them off too.

This Week's Top Stories: Nvidia Soars, a Better Best Buy & Dollar Tree Troubles

The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.

Neuralink Says FDA Approves Study of Human Brain Implants

Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.

Load More